KOP-based Recovery Centers of America is doing its part to help battle the COVID-19 virus. RCA’s GENETWORx Laboratories,a Virginia-based molecular laboratory certified in fifty states, announced that it will begin shipping at least 800 COVID-19 tests a day with the ability to increase capacity to 5,000 tests per day and up to 150,000 per month during April.With less than 100,000 people tested in the United States to date, the significant increase in COVID-19 tests made available by Genetworx, a subsidiary of Recovery Centers of America, will assist the nation in the battle against the deadly virus.
The company also stated that it will have the capability of providing results from the GENETWORx COVID-19 tests to patients in 24 hours upon receipt of sample.
The GENETWORx test follows the Centers for Disease Control (“CDC”) approved Assay kits required for sample testing for the Coronavirus genome. Since the outbreak of the coronavirus, GENETWORx has been working diligently to adapt their system to allow accurate, efficient testing of hundreds of samples for the COVID-19 genome in a few hours per run.
GENETWORx is working within the emergency use authorization guidelines from the United States Food and Drug Administration (“FDA”) to specifically conduct COVID-19 testing. GENETWORx is a CLIA-certified laboratory, owned by Recovery Centers of America, that meets regulatory requirements to perform high-complexity testing using their validated tests. The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments.
